District Judge John Bates wrote the removals harm “everyday Americans, and most acutely, underprivileged Americans, seeking ...
Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...
Relocating manufacturing would require substantial capital investment, but the timespan for the president’s new tariffs is unclear, supply chain experts said.
From the founders of BoldType comes CyberMed, a new company dedicated exclusively to MedTech cybersecurity. With a mission to ...
CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...
MGB said the layoffs were necessary to get ahead of an anticipated budget shortfall of $250 million over the next two years.
BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...
CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...
Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results